| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.879 | 25.663 | 23.986 | 20.354 | 26.551 | 27.480 | 20.805 | 27.698 | 26.147 | 25.673 |
| Total Income - EUR | 24.879 | 25.663 | 23.986 | 20.354 | 26.551 | 27.480 | 20.805 | 27.698 | 26.147 | 25.673 |
| Total Expenses - EUR | 18.204 | 20.192 | 18.610 | 16.784 | 24.009 | 17.035 | 13.626 | 22.757 | 17.265 | 12.961 |
| Gross Profit/Loss - EUR | 6.675 | 5.471 | 5.376 | 3.570 | 2.542 | 10.444 | 7.178 | 4.941 | 8.882 | 12.712 |
| Net Profit/Loss - EUR | 6.032 | 4.916 | 4.868 | 2.970 | 1.807 | 9.658 | 6.763 | 4.181 | 8.864 | 12.097 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
Check the financial reports for the company - Multi Bonimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 124 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.273 | 5.312 | 5.045 | 3.142 | 1.998 | 9.834 | 7.064 | 4.498 | 8.993 | 12.549 |
| Inventories | 3.345 | 2.298 | 1.253 | 325 | -398 | 2.426 | 3.075 | 3.334 | 2.411 | 2.206 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 2.928 | 3.014 | 3.792 | 2.817 | 2.396 | 7.408 | 3.990 | 1.164 | 6.582 | 10.343 |
| Shareholders Funds | 6.175 | 5.057 | 5.007 | 3.107 | 1.941 | 9.789 | 6.891 | 4.310 | 8.993 | 12.225 |
| Social Capital | 0 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 222 | 276 | 38 | 35 | 57 | 45 | 173 | 188 | 0 | 324 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Multi Bonimed S.r.l.